Mostrar registro simples

dc.contributor.authorBarros, Karina Margareti Alencar dept_BR
dc.contributor.authorSardi, Janaina de Cássia Orlandipt_BR
dc.contributor.authorNeto, Simone Mariapt_BR
dc.contributor.authorMacedo, Alexandre Josépt_BR
dc.contributor.authorRamalho, Suellen Rodriguespt_BR
dc.contributor.authorOliveira, Daniella Gorete Lourenço dept_BR
dc.contributor.authorPontes, Gemilson Soarespt_BR
dc.contributor.authorWeber, Simone Schneiderpt_BR
dc.contributor.authorOliveira, Caio Fernando Ramalho dept_BR
dc.contributor.authorMacedo, Maria Lígia Rodriguespt_BR
dc.date.accessioned2023-01-12T04:58:35Zpt_BR
dc.date.issued2021pt_BR
dc.identifier.issn0753-3322pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/253625pt_BR
dc.description.abstractErythrina poeppigiana belongs to Fabaceae family (subfamily Papillionoideae) and is commonly found in tropical and subtropical regions in Brazil. Herein, we described the purification and characterization of a new Kunitz-type inhibitor, obtained from E. poeppigiana seeds (EpTI). EpTI is composed by three isoforms of identical aminoterminal sequences with a molecular weight ranging from 17 to 20 kDa. The physicochemical features showed by EpTI are common to Kunitz inhibitors, including the dissociation constant (13.1 nM), stability against thermal (37–100 ◦C) and pH (2–10) ranging, and the presence of disulfide bonds stabilizing its reactive site. Furthermore, we investigated the antimicrobial, anti-adhesion, and anti-biofilm properties of EpTI against Grampositive and negative bacteria. The inhibitor showed antimicrobial activity with a minimum inhibitory concentration (MIC, 5–10 μM) and minimum bactericidal concentration (MBC) of 10 μM for Enterobacter aerogenes, Enterobacter cloacae, Klebsiella pneumoniae, Staphylococcus aureus, and Staphylococcus haemolyticus. The combination of EpTI with ciprofloxacin showed a marked synergistic effect, reducing the antibiotic concentration by 150%. The increase in crystal violet uptake for S. aureus and K. pneumoniae strains was approximately 30% and 50%, respectively, suggesting that the bacteria plasma membrane is targeted by EpTI. Treatment with EpTI at 1x and 10 x MIC significantly reduced the biofilm formation and prompted the disruption of a mature biofilm. At MIC/2, EpTI decreased the bacterial adhesion to polystyrene surface within 2 h. Finally, EpTI showed low toxicity in animal model Galleria mellonella. Given its antimicrobial and anti-biofilm properties, the EpTI sequence might be used to design novel drug prototypes.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofBiomedicine & pharmacotherapy. Paris. Vol. 144 (Dec. 2021), 112198, 11 p.pt_BR
dc.rightsOpen Accessen
dc.subjectInibidores de proteasespt_BR
dc.subjectPeptidase inhibitoren
dc.subjectAdherenceen
dc.subjectAntibacterianospt_BR
dc.subjectErythrina poeppigianaen
dc.subjectBiofilmespt_BR
dc.subjectAntibacterial activityen
dc.subjectAntibiofilm activityen
dc.titleA new Kunitz trypsin inhibitor from Erythrina poeppigiana exhibits antimicrobial and antibiofilm properties against bacteriapt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001157251pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples